Please assess the completion status of the following clinical trial:

Trial Title: Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patient is able to provide written assent and the parents or legal guardian of the patient is able to provide written informed consent before beginning and study related procedures~* Patient has a documented clinical diagnosis of Bipolar I mania~* Patient's parent or legal guardian will be able to accompany the patient at each scheduled study visit~Exclusion Criteria:~* Patients (female) must not be pregnant or lactating~* Patients with a known intolerance or lack of response to previous treatment with quetiapine~* Patients who have previously participated in this study

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).